Hans Lilja
141 – 150 of 469
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Identification of a Novel Proteoform of Prostate Specific Antigen (SNP-L132I) in Clinical Samples by Multiple Reaction Monitoring.
- Contribution to journal › Article
-
Mark
Association of cancer with moderately impaired renal function at baseline in a large, representative, population-based cohort followed for up to 30 years.
- Contribution to journal › Article
-
Mark
Integrated acoustic immunoaffinity-capture (IAI) platform for detection of PSA from whole blood samples.
- Contribution to journal › Article
-
Mark
Association of transcript levels of 10 established or candidate-biomarker gene targets with cancerous versus non-cancerous prostate tissue from radical prostatectomy specimens
- Contribution to journal › Article
-
Mark
Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study
- Contribution to journal › Article
-
Mark
Prospective randomized evaluation of risk-adapted prostate-specific antigen screening in young men : The PROBASE trial
- Contribution to journal › Article
-
Mark
Prostate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection
- Contribution to journal › Scientific review
-
Mark
Suitability of quality control materials for prostate-specific antigen (PSA) measurement : Inter-method variability of common tumor marker control materials
- Contribution to journal › Article
-
Mark
Preclinical radioimmunotherapy of prostate cancer with 177Lu-11B6, a 177Lu-labeled monoclonal antibody specifically targeting free, unbound human kallikrein-related peptidase 2
- Contribution to journal › Published meeting abstract
- 2012
-
Mark
PSA is Dead, Long Live PSA
- Contribution to journal › Debate/Note/Editorial
